Option chain shows key data for JetBlue Airways's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for JetBlue Airways.

JetBlue Airways (NASDAQ:JBLU) Stock, Option Chain

JetBlue Airways

NASDAQ:JBLU

nyse:dal

nyse:ual

Southern Winter Storm Hinders Travel

The Unintended Consequences of Airline Regulations

U.S. Airlines&#39; Price Hikes

Most of the time, we ignore insider selling. Insiders can sell for a host of reasons, such as estate planning, life changes, and liquidity needs.
At younger, fast-growing companies, insiders are much more likely to be sellers, as insiders cash in returns on their initial investments in the company.
A stock sale by a corporate VP who needs a few hundred grand to pay his kid&#8217;s Harvard tuition bill has little to do with the company&#8217;s future expectations.
Academic research and practical experience demonstrate that insider or open market purchases are more important than insider selling.
There is, of course, an exception to the rule. When we see a group of insiders selling stocks near 52-week lows, there is valuable information to be gained. It is highly unlikely that they all needed cash for tuition or a dream home at the same time.
Unless several insiders had an emergency need for cash simultaneously that was so dire they would sell a stock at a low price, an insider selling cluster near the lows tells us something important.
In the immortal words of Sherlock Holmes, &#8220;The game is afoot!&#8221;
Something is happening at the company that has several insiders of the opinion that they need to sell now, as a higher price is unlikely to be in the cards for the foreseeable future. Something has gone wrong, or the company&#8217;s product is falling out of favor.
You and I may not be able to determine precisely what is bad, but the combination of weak price action and insider selling clearly indicates that something is amiss.
That appears to be the case at Constellation Brands (Ticker: STZ). While its core products rarely go out of demand, shares of the beer, wine, and spirits company have been extraordinarily weak over the past year. Insiders have been selling as the stock price declined.
Did insiders know or suspect the Surgeon General would announce the need for a cancer warning on alcohol bottles?
&nbsp;Is there some shift in the public&#8217;s desire for intoxicating beverages? We do not know. The Securities and Exchange Commission requires that insiders announce transactions.
They do not require them to provide their reasoning.
We do know that sales growth has been slowing, earnings are falling, and Wall Street analysts have been lowering their estimates for the next year. If insiders saw some light at the end of the tunnel, we would expect to see some buying.
We have not.
&nbsp;Instead, we have seen a steady stream of sales from the company&#8217;s top executives, including the CEO.
The stock could reverse course and go higher. That would not be the smart play until insiders express their belief in the future with their cash.
We are also seeing a cluster of insider selling in stocks that have dropped close to the 52-week lows in the same industry.
The odds of executives and directors at several companies in the same industries all having immediate cash needs are so small that this grabs my attention.
We know that there is a shortage of houses in the United States. With a 4% average rate for people with a mortgage and more than half of all homes owned by folks over 55, a massive shortage of existing home inventory has developed. It is not going to change anytime soon.
That should spell boom times ahead for builders, but that has not developed yet. While we may see more activity in 2025 than in 2024, it will still be well below the historic average of building activity.
As we start the year, there is a lot of uncertainty about the economy and interest rates. Mortgage rates are highly unlikely to return to 2021 levels, and there is a whole generation of buyers that are struggling to wrap their heads around the new normal.
Some builders may be talking about great earnings for the year, but we are seeing many insiders quietly selling stock to tuck some cash away for a rainy day. They are selling despite recent price weakness.
&nbsp;Dream Finders (Ticker: DFH), Hovnanian (Ticker: HOV), and Landsea Homes (Ticker: LSEA) have seen clusters of selling near the 52-week lows in the last few months.
I am a big believer in the eventual boom cycle for homebuilders.
Either that or we become a nation of renters like we were before the GI Bill and 30-year mortgage created the modern American dream of the house with two cars in the garage, a white picket fence, and a homeowners association that would make Stalin blush with envy.
Right now, industry fundamentals are uneven, and insiders are less than enthusiastic. When we see a cluster of insiders buying at several homebuilders, it will be time to be enthusiastic buyers. That time is not now.

Opinion

LSEA

C-Suite Buy of the Week: Discover What Insider Selling Patterns Mean for Your Investments

Options

Markets

XPEV

XPeng Option Alert: Mar 21 $24 Calls Sweep (21) near the Ask: 2421 @ $0.141 vs 5044 OI; Ref=$12.263

Maxim Group analyst Michael Okunewitch maintains Lineage Cell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LCTX#AMEX">LCTX</a>) with a Buy and lowers the price target from $5 to $3.

News

Price Target

Analyst Ratings

LCTX

Maxim Group Maintains Buy on Lineage Cell Therapeutics, Lowers Price Target to $3

Bernstein analyst Eve Burstein maintains Natera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>) with a Outperform and raises the price target from $160 to $200.

NTRA

Bernstein Maintains Outperform on Natera, Raises Price Target to $200

Calidi Biotherapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#NASDAQ">CLDI</a>) shares are trading lower by 32% to 92 cents during Friday&#8217;s session after the company priced its public offering of 5 million shares of common stock at $0.85 per share, aiming to raise approximately $4.25 million in gross proceeds. 
The offering is set to close on January 10, pending customary closing conditions. Ladenburg Thalmann &amp; Co. Inc. is the exclusive placement agent for the transaction. 
Calidi says the company plans to use the proceeds for working capital and general corporate purposes.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42917321/consumer-inflation-worries-highest-since-2008-u-of-m-survey-says-wall-street-tumbles-to-2-month-lows">Consumer Inflation Worries Highest Since 2008, U Of M Survey Says: Wall Street Tumbles To 2-Month Lows</a>
<h2 class="wp-block-heading">Should I Sell My CLDI Stock?</h2>
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
Shares of Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) have lost 92.85% year to date. This compares to the average annual return of -76.04%, meaning the stock has underperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity. 
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Calidi Biotherapeutics stock currently has an RSI of 55.44, indicating neutral conditions.
For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a> 
CLDI has a 52-week high of $16.80 and a 52-week low of $0.73.

CLDI

Why Calidi Biotherapeutics (CLDI) Stock Is Down 30%

WIIM

Calidi Biotherapeutics shares are trading lower after the company announced the pricing of a 5 million share offering at $0.85 per share.

BTIG analyst Justin Zelin initiates coverage on ImmunityBio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) with a Buy rating and announces Price Target of $6.

Initiation

IBRX

BTIG Initiates Coverage On ImmunityBio with Buy Rating, Announces Price Target of $6

<a href="https://www.barrons.com/articles/paysafe-stock-price-acquisition-967df3be?mod=hp_latestnews" title="https://www.barrons.com/articles/paysafe-stock-price-acquisition-967df3be?mod=hp_latestnews">https://www.barrons.com/articles/paysafe-stock-price-acquisition-967df3be?mod=hp_latestnews</a>

Trading Ideas

PSFE

Watching Paysafe; Traders Circulate Barron's Article Titled "Paysafe Stock Could More Than Double. The Case for an Acquisition"; Shares See A Pop In Volume

TMDX

TransMedics shares are trading lower following a report by Scorpion Capital assigning the company a $0 price target.

Oil prices are heating up, and so are the stocks of <a href="https://www.benzinga.com/topic/energy">major energy companies</a>. 
Shares of Chevron Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>), Occidental Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>), and ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) were trading in the green at the last check on Friday. The rally follows a Reuters report suggesting the U.S. is preparing its most <a href="https://www.benzinga.com/etfs/sector-etfs/25/01/42919047/oil-nears-80-as-us-prepares-new-russia-sanctions">stringent sanctions yet</a> against Russian oil.
These sanctions, expected to target 180 vessels, major <a href="https://www.benzinga.com/topic/oil?_gl=1&#x2A;1aeuuae&#x2A;_gcl_au&#x2A;MTQ3Nzg4MTMxMi4xNzM1NTczMTA3&#x2A;_ga&#x2A;R1MxLjEuMTczNjUyMjc2NC4xLjEuMTczNjUyMjg4Ni4wLjAuMA..&#x2A;_ga_V7ZK73W7N0&#x2A;MTczNjUyMDk1NC40Ni4xLjE3MzY1MjY3NDYuMC4wLjA.">oil </a>companies, and top executives, have already pushed oil prices to $80 per barrel — a level not seen since October 2024. 
Traders are responding to the anticipated disruption in global oil supply, and some ETFs with oil and energy exposure stand to reap the benefits.
<h3 class="wp-block-heading">What This Means For ETFs</h3>
<ul>
<li>The United States Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>) was trading 3.73% higher as of 12.13 P.M. EST</li>
<li>The Invesco DB Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBO#NYSE">DBO</a>) rose about 3.84%. </li>
<li>The United States 12 Month Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USL#NYSE">USL</a>) posted a 2.21% gain.</li>
<li>The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOP#NYSE">XOP</a>), with an expense ratio of 0.09% and a 91.26% exposure to the Oil, Gas &amp; Consumable Fuels make it a good bet for investors of oil-focused ETFs. The portfolio includes Exxon Mobil, Chevron and ConocoPhillips.</li>
<li>Vanguard Energy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VDE#NYSE">VDE</a>) has an expense ratio of 0.10% and like XOP, Exxon Mobil, Chevron and ConocoPhillips enjoys significant weightage in the fund.</li>
</ul>
<h3 class="wp-block-heading">Geopolitics and Market Dynamics</h3>
Sanctions on Russia — one of the world's largest oil producers — are expected to tighten supply. Prices are expected to go higher. Ongoing reduction in U.S. crude stockpiles, particularly at the Cushing, Oklahoma hub, as reported by Reuters, adds to the pressure.
While tighter supplies drive prices upward, concerns about demand persist. China&#8217;s fuel oil imports are likely to fall early 2025 thanks to a hike in oil import tax from Jan. 1. 
Weaker demand from China, one of the biggest crude oil importers, could weigh on prices in the longer term. 
See Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42340255/opec-extends-oil-output-cuts-to-late-2026-what-it-means-for-markets">OPEC+ Extends Oil Output Cuts To Late 2026: What It Means For Markets</a></li>
</ul>
Photo: Shutterstock

Sector ETFs

ETFs

Oil Stocks Rally On Anticipation Of Stricter Russian Sanctions: Here's How ETFs Are Reacting

United Parcel Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) shares are <a target="_blank" href="https://www.benzinga.com/quote/UPS/analyst-ratings" rel="noreferrer noopener">trading lower on Thursday.</a>
JP Morgan analyst Brian P. Ossenbeck <a target="_blank" href="https://www.benzinga.com/quote/UPS/analyst-ratings" rel="noreferrer noopener">reiterated the Neutral rating</a> on United Parcel Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>).
The analyst notes that the contract between UPS and the United States Postal Service (USPS) for SurePost expired on December 31, 2024, and it seems the two companies did not reach a new agreement.
This is separate from the air cargo contract UPS secured with FedEx Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) in 2024.
Ossenbeck views the situation as a long-term positive for UPS and parcel pricing, but questions how well the company can handle the transition of SurePost volume immediately after peak season, given that FedEx estimated a similar transition would take about a year. The analyst <a target="_blank" href="https://www.benzinga.com/quote/FDX/analyst-ratings" rel="noreferrer noopener">reiterated the Overweight rating on FedEx</a>.
The analyst suggests that UPS may be following a similar strategy to FedEx, which in-sourced its SmartPost service to save on USPS delivery fees and improve cost efficiency.
The analyst expects UPS to discuss the strategic rationale and financial implications in the fourth-quarter earnings call on January 30.
Also Read: <a target="_blank" href="https://www.benzinga.com/economics/macro-economic-events/25/01/42917321/consumer-inflation-worries-highest-since-2008-u-of-m-survey-says-wall-street-tumbles-to-2-month-lows" rel="noreferrer noopener">Consumer Inflation Worries Highest Since 2008, U Of M Survey Says: Wall Street Tumbles To 2-Month Lows</a>
At the time, FedEx was also aiming for a seven-day residential delivery network, which has since been scaled back.
Ossenbeck acknowledges UPS could handle the added volume under a new brand (possibly &#8220;Ground Saver&#8221;), eventually reducing service areas it cannot reach.
The analyst has previously emphasized that parcel carriers need to get &#8220;Better and Smaller,&#8221; and views this as a positive first step, though he doesn&#8217;t expect significant delivery density improvements, as even during the COVID-19 boom, those benefits were not realized.
Ossenbeck highlights potential execution risks for UPS, including package car capacity constraints and challenges in integrating SurePost during peak return periods.
There is also uncertainty about whether the recent Teamsters&#8217; contract limits SurePost deliveries, as drivers have previously focused on larger packages for redirection.
For FedEx, the analyst suggests that its Ground Economy service could benefit if United Parcel and USPS continue to raise rates for the most economical delivery services, thus increasing the price floor for deferred products.
Price Action: UPS shares are trading lower by 2.86% to $123.14 at last check Friday, while FDX shares are trading lower by 1.24% to $271.40.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42912208/delta-stock-jumps-after-record-q4-earnings-and-strong-2025-outlook" target="_blank" rel="noreferrer noopener">Delta Takes Flight As Q4 Earnings Beat Expectations, Fueled By Premium Travel Demand And Efficiency Gains</a></li>
</ul>
Image via Shutterstock.

Analyst Color

Equities

Reiteration

Movers

General

UPS Faces Post-SurePost Challenges: Analyst Sees Long-Term Gain But Near-Term Hurdles

Stephens &amp; Co. analyst Charles Nabhan downgrades Global Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) from Overweight to Equal-Weight and lowers the price target from $125 to $120.

Downgrades

Stephens & Co. Downgrades Global Payments to Equal-Weight, Lowers Price Target to $120

Stephens &amp; Co. analyst Charles Nabhan downgrades Paycor HCM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYCR#NASDAQ">PYCR</a>) from Overweight to Equal-Weight and raises the price target from $20 to $22.5.

PYCR

Stephens & Co. Downgrades Paycor HCM to Equal-Weight, Raises Price Target to $22.5

Sweetgreen shares are trading higher after Citigroup upgraded the stock from Neutral to Buy and raised its price target from $44 to $49.

Martin Marietta Materials's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLM#NYSE">MLM</a>) short percent of float has fallen 8.97% since its last report. The company recently reported that it has 1.42 million shares sold short, which is 2.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.67 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Martin Marietta Materials Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736532921_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Martin Marietta Materials has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Martin Marietta Materials's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Martin Marietta Materials's peer group average for short interest as a percentage of float is 4.01%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Martin Marietta Materials?

Zoetis's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZTS#NYSE">ZTS</a>) short percent of float has risen 14.88% since its last report. The company recently reported that it has 6.26 million shares sold short, which is 1.39% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.82 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Zoetis Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736532916_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Zoetis has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Zoetis's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Zoetis's peer group average for short interest as a percentage of float is 7.01%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Zoetis?

AGNC Investment's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGNC#NYSE">AGNC</a>) short percent of float has fallen 11.55% since its last report. The company recently reported that it has 41.93 million shares sold short, which is 4.75% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.1 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>AGNC Investment Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736532911_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AGNC Investment has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing AGNC Investment's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, AGNC Investment's peer group average for short interest as a percentage of float is 3.74%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

AGNC

(AGNC) - Analyzing AGNC Investment's Short Interest

Walgreens Boots Alliance, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) shares are trading significantly higher Friday. The company posted earnings that <a href="https://www.benzinga.com/general/health-care/25/01/42912519/walgreens-boots-alliance-stock-jumps-on-better-than-expected-q1-earnings-sticks-to-annual-profit-forecast">were higher than estimates</a>.
The stock may be breaking out and it looks like it can go even higher. This is why our team of traders and technical analysts have made it our Stock of the Day.
Walgreens reported first quarter earnings of 51 cents per share. Analysts were looking for 37 cents.
Revenue also beat estimates. Sales were $30.90 billion, which was ahead of the $29.10 billion The Street was looking for.
When a stock is trending higher, there are more shares to be bought than sold. Traders and investors who wish to acquire shares are forced to bid premiums to get sellers interested. This results in an uptrend.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="555" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10131253/1-3-1024x555.png" alt="" class="wp-image-728742" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10131253/1-3-1024x555.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10131253/1-3-300x163.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10131253/1-3-768x416.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10131253/1-3.png 1489w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42917321/consumer-inflation-worries-highest-since-2008-u-of-m-survey-says-wall-street-tumbles-to-2-month-lows">Consumer Inflation Worries Highest Since 2008, U Of M Survey Says: Wall Street Tumbles To 2-Month Lows</a>
But when a stock reaches a resistance level, the dynamic changes. There is a large amount of sell orders. People can buy as many shares as they want without having to push the price higher.
As you can see on the chart, $11 has been resistance for Walgreens. In October and December when it reached this level, the rallies ended.
Sometimes, a stock sells off after reaching resistance. This happens when some of the sellers who created the resistance start to undercut each other. They know the buyers will go to whoever wants to sell at the lowest price.
These sellers don't want to miss the trade, so they reduce their offering prices. Other sellers see this and do the same. This undercutting can result in a snowball effect that pushes the price lower.
But sometimes when a stock reaches a resistance level, the buyers eventually overpower the sellers and push the price above the resistance. When this happens, traders say it is a breakout.
This shows people who created the resistance with their sell orders have left the market. They have finished or canceled their orders.
Buyers will once again be forced to bid premiums to draw sellers back into the market. This can result in a new uptrend forming, and it may be about to happen with Walgreens.
Read Next: • <a href="https://www.benzinga.com/news/25/01/42916780/donald-trump-receives-unconditional-discharge-in-new-york-hush-money-case-will-enter-white-house-as-convicted-felon">Donald Trump Receives Unconditional Discharge In New York Hush Money Case, Will Enter White House As Convicted Felon</a>
Photo: Shutterstock

Health Care

Technicals

Stock Of The Day: Is Walgreens Breaking Out?

Loop Capital analyst Garik Shmois maintains Owens-Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>) with a Buy and lowers the price target from $215 to $210.

Loop Capital Maintains Buy on Owens-Corning, Lowers Price Target to $210

JetBlue Airways Corporation - Common Stock

Comments

JetBlue Airways

JetBlue Airways (NASDAQ:JBLU) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga